- Home
- LXEO vs SOR Comparison
LXEO vs SOR Comparison
Compare LXEO & SOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- SOR
- Stock Information
- Founded
- LXEO 2017
- SOR 1968
- Country
- LXEO United States
- SOR United States
- Employees
- LXEO N/A
- SOR N/A
- Industry
- LXEO
- SOR Investment Managers
- Sector
- LXEO
- SOR Finance
- Exchange
- LXEO Nasdaq
- SOR Nasdaq
- Market Cap
- LXEO 314.1M
- SOR 361.3M
- IPO Year
- LXEO 2023
- SOR N/A
- Fundamental
- Price
- LXEO $6.29
- SOR $44.44
- Analyst Decision
- LXEO Strong Buy
- SOR
- Analyst Count
- LXEO 7
- SOR 0
- Target Price
- LXEO $22.71
- SOR N/A
- AVG Volume (30 Days)
- LXEO 623.4K
- SOR 16.2K
- Earning Date
- LXEO 11-13-2024
- SOR 01-01-0001
- Dividend Yield
- LXEO N/A
- SOR 7.24%
- EPS Growth
- LXEO N/A
- SOR N/A
- EPS
- LXEO N/A
- SOR 6.50
- Revenue
- LXEO N/A
- SOR N/A
- Revenue This Year
- LXEO N/A
- SOR N/A
- Revenue Next Year
- LXEO N/A
- SOR N/A
- P/E Ratio
- LXEO N/A
- SOR $6.41
- Revenue Growth
- LXEO N/A
- SOR N/A
- 52 Week Low
- LXEO $5.77
- SOR $36.41
- 52 Week High
- LXEO $22.33
- SOR $42.75
- Technical
- Relative Strength Index (RSI)
- LXEO 28.99
- SOR 41.30
- Support Level
- LXEO $5.77
- SOR $44.08
- Resistance Level
- LXEO $11.72
- SOR $44.86
- Average True Range (ATR)
- LXEO 0.85
- SOR 0.54
- MACD
- LXEO -0.19
- SOR -0.08
- Stochastic Oscillator
- LXEO 5.71
- SOR 2.33
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
About SOR Source Capital Inc.
Source Capital Inc is a diversified, closed-end management investment company. The investment objective of the company is to seek maximum total return for Common shareholders from both capital appreciation and investment income to the extent consistent with the protection of invested capital.